Fungal detection test for lung infections in blood cancer patients
Part of Blood & lymphatic, Infections, Lungs & breathing clinical trials.
This study uses a blood test to find fungal lung infections in people with blood cancers or those who had a stem cell transplant. It may help doctors diagnose and treat infections faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 14 years or older and have a blood cancer like leukemia, lymphoma, or myeloma, or you have had a stem cell transplant.
- A CT scan shows spots or lesions in your lungs.
- You have symptoms like fever, cough, or trouble breathing that might be from a fungal infection.
- Other tests (like blood cultures) have not found another cause for your symptoms.
- You have at least one risk factor, such as a low white blood cell count, long-term steroid use, graft-versus-host disease, CMV infection, or taking drugs that suppress T cells.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to find infections (using a test called mNGS) that may be quicker and more accurate than standard tests. It is for people with blood cancers who show signs of a possible fungal infection, like fever or abnormal lung scans.
This trial tests a combination of antifungal medicines (liposomal amphotericin B and either isavuconazole or posaconazole) for people with blood cancers who develop a fungal infection despite taking preventive antifungal drugs. It aims to find a better treatment for these difficult infections.
This study is testing a new blood or fluid test that may find drug-resistant fungus in people with a weakened immune system who have a serious lung infection. The results could help doctors choose the right medicine faster.
This study uses noninvasive breathing/relates imaging (MRI or CT) to help diagnose mold infections in the lungs in children and young adults. It may help doctors find these infections sooner, especially in people with weakened immune systems.
This trial checks whether a PET-CT scan using a small amount of tracer (FDG) can help doctors better identify invasive fungal infections inside the body. It may be useful for guiding diagnosis when standard information is unclear.
This trial tests if a simple breath analysis can detect invasive fungal infections early in people with acute leukemia who are undergoing chemotherapy and have a low white blood cell count. Early detection could help start treatment sooner.
Hear when a new Invasive Pulmonary Fungal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.